The dsRBP and inactive editor ADR-1 utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome.
Michael C Washburn, Boyko Kakaradov, Balaji Sundararaman, Emily Wheeler, Shawn Hoon, Gene W Yeo, Heather A Hundley
Cell reports · 2014 · Vol. 6 (4) · pp. 599-607
Abstract
Inadequate adenosine-to-inosine editing of noncoding regions occurs in disease but is often uncorrelated with ADAR levels, underscoring the need to study deaminase-independent control of editing. C. elegans have two ADAR proteins, ADR-2 and the theoretically catalytically inactive ADR-1. Using high-throughput RNA sequencing of wild-type and adr mutant worms, we expand the repertoire of C. elegans edited transcripts over 5-fold and confirm that ADR-2 is the only active deaminase in vivo. Despite lacking deaminase function, ADR-1 affects editing of over 60 adenosines within the 3' UTRs of 16 different mRNAs. Furthermore, ADR-1 interacts directly with ADR-2 substrates, even in the absence of ADR-2, and mutations within its double-stranded RNA (dsRNA) binding domains abolish both binding and editing regulation. We conclude that ADR-1 acts as a major regulator of editing by binding ADR-2 substrates in vivo. These results raise the possibility that other dsRNA binding proteins, including the inactive human ADARs, regulate RNA editing through deaminase-independent mechanisms.
Linked datasets 1
The dsRBP and inactive editor, ADR-1, utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome
6239
16 data files
| File | Type | Size |
|---|---|---|
| Sample_ADR12.fastq.gz | RNA-Seq | 12.4 GB |
| Sample_ADR1.fastq.gz | RNA-Seq | 1.6 GB |
| Sample_ADR2.fastq.gz | RNA-Seq | 1.8 GB |
| Sample_DS12MT.fastq.gz | RNA-Seq | 1.7 GB |
| Sample_DS1MT.fastq.gz | RNA-Seq | 1.7 GB |
| Sample_DS2MT.fastq.gz | RNA-Seq | 1.7 GB |
| Sample_WADR1.fastq.gz | RNA-Seq | 1.8 GB |
| SRR1015363_GSM1248093 | RNA-Seq | 12.4 GB |
| SRR1015364_GSM1248097 | RNA-Seq | 1.6 GB |
| SRR1015365_GSM1248099 | RNA-Seq | 1.8 GB |
| SRR1015366 | RNA-Seq | 1.5 GB |
| SRR1015366_GSM1248101 | RNA-Seq | 1.5 GB |
| SRR1015367_GSM1248103 | RNA-Seq | 1.7 GB |
| SRR1015368_GSM1248105 | RNA-Seq | 1.7 GB |
| SRR1015369_GSM1248107 | RNA-Seq | 1.7 GB |
| SRR1015370_GSM1248109 | RNA-Seq | 1.8 GB |
Potentially related datasets 1
These accessions were text-mined from the PMC full text. They may be referenced for comparison, cited from other studies, or otherwise mentioned without being primary data for this paper.
Analysis pipelines 1
| Pipeline | Assay | Steps | Dataset |
|---|---|---|---|
| GSE51556 RNA-seq Data Processing geo_data_processing | RNA-seq | 14 | GSE51556 |
Funding 5 grants
| Grant | Funder |
|---|---|
| R01 HG004659 | NHGRI NIH HHS (United States) |
| P30 CA023100 | NCI NIH HHS (United States) |
| T32 GM008666 | NIGMS NIH HHS (United States) |
| R01 NS075449 | NINDS NIH HHS (United States) |
| T32 GM007757 | NIGMS NIH HHS (United States) |